These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6311375)

  • 1. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor.
    Martodam RR; Thornton KS; Sica DA; D'Souza SM; Flora L; Mundy GR
    Calcif Tissue Int; 1983 Jul; 35(4-5):512-9. PubMed ID: 6311375
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of thionapthene-2-carboxylic acid-lysine on the hypercalcemia of malignancy in the rat.
    Decker JE; Morrison NE; Lorenzo JA; Samour CM; McCarron BA; Raisz LG
    Calcif Tissue Int; 1989 Jan; 44(1):61-4. PubMed ID: 2521808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal phosphate transport in humoral hypercalcemia of malignancy.
    Sartori L; Insogna KL; Barrett PQ
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1078-84. PubMed ID: 2974244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy.
    Tfelt-Hansen J; Chattopadhyay N; Yano S; Kanuparthi D; Rooney P; Schwarz P; Brown EM
    Endocrinology; 2004 Mar; 145(3):1211-7. PubMed ID: 14645111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative effects of dichloromethylene diphosphonate (C12MDP) and ethane-1-hydroxy-1,1-diphosphonate (EHDP) on growth and modeling of the rat tibia.
    Miller SC; Jee WS
    Calcif Tissue Res; 1977 Oct; 23(3):207-14. PubMed ID: 143335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of dichloromethylene diphosphonate and vitamin D on bone of thyroparathyroidectomized rats.
    Weisbrode SE; Capen CC; Pendley CB
    Am J Pathol; 1977 Oct; 89(1):137-52. PubMed ID: 143891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM; Morris CA; Mitnick MA; Insogna KL
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES; Hyman GA; Canfield RE
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
    Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
    Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.
    Evans RA; Wergedal JE; Baylink DJ
    Miner Electrolyte Metab; 1983; 9(3):119-24. PubMed ID: 6224075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.
    Miller SC; Jee WS
    Anat Rec; 1979 Mar; 193(3):439-62. PubMed ID: 154858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy.
    Ibbotson KJ; D'Souza SM; Ng KW; Osborne CK; Niall M; Martin TJ; Mundy GR
    Science; 1983 Sep; 221(4617):1292-4. PubMed ID: 6577602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High extracellular calcium increases the production of a parathyroid hormone-like activity by cultured Leydig tumor cells associated with humoral hypercalcemia.
    Rizzoli R; Bonjour JP
    J Bone Miner Res; 1989 Dec; 4(6):839-44. PubMed ID: 2610020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
    Troyer H; Sowers JR; Babich E
    Am J Pathol; 1982 Sep; 108(3):284-90. PubMed ID: 7114164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancy.
    Sica DA; Martodam RR; Aronow J; Mundy GR
    Calcif Tissue Int; 1983 May; 35(3):287-93. PubMed ID: 6871760
    [No Abstract]   [Full Text] [Related]  

  • 20. Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors.
    Tam CS; Heersche JN; Santora A; Spiegel AM
    Metabolism; 1984 Jan; 33(1):50-3. PubMed ID: 6690886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.